Drug Trial Radar · NCT05795699
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Last checked: Nov 19, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
107
Actual
Start
Mar 30, 2023
Primary completion
May 22, 2025
Study completion Feb 20, 2026
Sponsor
- Lead sponsor
- Kowa Research Institute, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Conditions
- Fuchs Endothelial Corneal Dystrophy
Interventions
RipasudilDrug
K-321 ophthalmic solution
PlaceboDrug
Placebo ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to improvement in best corrected (distance) visual acuity (BCVA) by ETDRS letter score during the first 12 weeksTime frame: Baseline to Week 12
Locations
50 sites in 6 countries. Site status is shown where the registry gives one.
Keck Hospital of USC
Los Angeles, California
Macy Eye Center
Los Angeles, California
Jules Stein Eye Institute
Los Angeles, California
Byers Eye Institute at Stanford
Palo Alto, California
Sacramento Eye Consultants
Sacramento, California
Gorovoy MD Eye Specialists
Fort Myers, Florida
University of Florida
Gainesville, Florida
Bascom Palmer Eye Institute
Miami, Florida
Bascom Palmer Eye Institute - Naples
Naples, Florida
Eye Consultants of Atlanta
Atlanta, Georgia
Grene Vision Group
Wichita, Kansas
University of Kentucky
Lexington, Kentucky
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
W Kellogg Eye Center
Ann Arbor, Michigan
Verdier Eye Center
Grand Rapids, Michigan
Vance Thompson Vision - Omaha
Omaha, Nebraska
Eye Associates of New Mexico
Albuquerque, New Mexico
NYU Langone Health
New York, New York
Vance Thompson Vision West Fargo
West Fargo, North Dakota
University Hospitals Cleveland Medical Center - 11100 Euclid Ave
Cleveland, Ohio
Devers Eye Institute
Portland, Oregon
Casey Eye Institute - OHSU
Portland, Oregon
University of Texas Southwestern Medical Center
Dallas, Texas
Houston Eye Associates
Houston, Texas
R and R Eye Research, LLC.
San Antonio, Texas
University of Wisconsin - 2870 University Ave
Madison, Wisconsin
Dr. Greg Moloney
Vancouver, British Columbia, Canada
Prism Eye Institute - Mississauga-Oakville
Oakville, Ontario, Canada
Precision Cornea Centre
Ottawa, Ontario, Canada
Ottawa Hospital
Ottawa, Ontario, Canada
Rigshospitalet Glostrup-Nordre Ringvej 57
Glostrup Municipality, Capital, Denmark
Aarhus Universitetshospital
Aarhus N, Central Jutland, Denmark
LMU Klinikum der Universität
München, Germany
Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany
Universitatsklinkum Erlangen-Ulmenweg 18
Erlangen, Bavaria, Germany
Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany
Universitatsklinikum Dusseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Universität des Saarlandes
Homburg, Saarland, Germany
Universitatsklinikum Leipzig
Leipzig, Saxony, Germany
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.